SNP mapping and candidate gene sequencing in the class I region of the HLA complex: Searching for multiple sclerosis susceptibility genes in Tasmanians

Tissue Antigens

Volumn 71, Issue 1, 2008, Pages 42-50

  Burfoot, R K ^a   Jensen, C J ^a   Field, J ^a   Stankovich, J ^b,c   Varney, M D ^d   Johnson, L J ^a   Butzkueven, H ^a,e   Booth, D ^f   Bahlo, M ^b   Tait, B D ^d   Taylor, B V ^g   Speed, T P ^b   Heard, R ^f   Stewart, G J ^f   Foote, S J ^c   Kilpatrick, T J ^a,e   Rubio, J P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Class I; HLA complex; Multiple sclerosis; Susceptibility; Tasmania

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; HLA A ANTIGEN; HLA DR ANTIGEN; HLA F ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UBIQUITIN; UBIQUITIN D; UNCLASSIFIED DRUG;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE MAPPING; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMELLING;

CASE-CONTROL STUDIES; CHROMOSOME MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TASMANIA;

EID: 36949031696     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2007.00962.x     Document Type: Article

References (33)

1. Serjeantson SW, Gao X, Hawkins BR, Higgins DA, Yu YL. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur J Immunogenet 1992 : 19 : 11 9.
2. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R, Eraksoy M. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol 1997 : 55 : 59 65.
3. Coraddu F, Reyes-Yanez MP, Parra A et al. HLA associations with multiple sclerosis in the Canary Islands. J Neuroimmunol 1998 : 87 : 130 5.
4. Stewart GJ, Teutsch SM, Castle M, Heard RN, Bennetts BH. HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients. Eur J Immunogenet 1997 : 24 : 81 92.
5. Rubio JP, Bahlo M, Butzkueven H et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet 2002 : 70 : 1125 37.
6. Modin H, Olsson W, Hillert J, Masterman T. Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. Am J Hum Genet 2004 : 74 : 1321 2.
7. Dyment DA, Herrera BM, Cader MZ et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005 : 14 : 2019 26.
8. Barcellos LF, Sawcer S, Ramsay PP et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006 : 15 : 2813 24.
9. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000 : 55 : 140 8.
10. Marrosu MG, Murru R, Murru MR et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001 : 10 : 2907 16.
11. Harbo HF, Lie BA, Sawcer S et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004 : 63 : 237 47.
12. Yeo TW, De Jager PL, Gregory SG et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 2007 : 61 : 228 36.
13. Rubio JP, Bahlo M, Stankovich J et al. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients. Immunogenetics 2007 : 59 : 177 86.
14. Lincoln MR, Montpetit A, Cader MZ et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005 : 37 : 1108 12.
15. Rubio JP, Bahlo M, Tubridy N et al. Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Hum Genet 2004 : 114 : 573 80.
16. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 : 13 : 227 31.
17. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 : 50 : 121 7.
18. Paty DW, Oger JJ, Kastrukoff LF et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988 : 38 : 180 5.
19. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998 : 63 : 259 66.
20. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002 : 30 : 97 101.
21. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995 : 59 : 97 105.
22. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 : 21 : 263 5.
23. Bahlo M, Stankovich J, Speed TP, Rubio JP, Burfoot RK, Foote SJ. Detecting genome wide haplotype sharing using SNP or microsatellite haplotype data. Hum Genet 2006 : 119 : 38 50.
24. D'Alfonso S, Bolognesi E, Guerini FR et al. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun. 2007, doi:10.1038/sj.gene.6364437.
25. Wiendl H, Feger U, Mittelbronn M et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 2005 : 128 : 2689 704.
26. Ober C, Aldrich CL, Chervoneva I et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003 : 72 : 1425 35.
27. Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells. Hum Reprod 2006 : 21 : 1743 8.
28. Hilton AA, Slavin AJ, Hilton DJ, Bernard CC. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J Neurochem 1995 : 65 : 309 18.
29. Roth MP, Dolbois L, Borot N, Pontarotti P, Clanet M, Coppin H. Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: no evidence of disease association with MOG. J Neuroimmunol 1995 : 61 : 117 22.
30. Rodriguez D, Della Gaspera B, Zalc B et al. Identification of a Val 145 Ile substitution in the human myelin oligodendrocyte glycoprotein: lack of association with multiple sclerosis. The Reseau de Recherche Clinique INSERM sur la Susceptibilite Genetique a la Sclerose en Plaques. Mult Scler 1997 : 3 : 377 81.
31. Gomez-Lira M, Moretto G, Bonamini D et al. Myelin oligodendrocyte glycoprotein polymorphisms and multiple sclerosis. J Neuroimmunol 2002 : 133 : 241 3.
32. Ohlenbusch A, Pohl D, Hanefeld F. Myelin oligodendrocyte gene polymorphisms and childhood multiple sclerosis. Pediatr Res 2002 : 52 : 175 9.
33. Marrosu MG, Murru R, Costa G et al. Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population. BMC Genet 2007 : 8 : 25.